Form 8-K - Current report:
SEC Accession No. 0001140361-22-002013
Filing Date
2022-01-19
Accepted
2022-01-19 16:30:25
Documents
12
Period of Report
2022-01-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K brhc10032937_8k.htm   iXBRL 8-K 39837
  Complete submission text file 0001140361-22-002013.txt   178152

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pdsb-20220119.xsd EX-101.SCH 3929
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE pdsb-20220119_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pdsb-20220119_pre.xml EX-101.PRE 16046
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10032937_8k_htm.xml XML 4239
Mailing Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932
Business Address 25B VREELAND ROAD SUITE 300 FLORHAM PARK NJ 07932 800-208-3343
PDS Biotechnology Corp (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37568 | Film No.: 22539137
SIC: 2834 Pharmaceutical Preparations